Source: Chicago Tribune
Date: April 11, 2007
Summary:
The Chicago Tribune examines the potential benefits and risks of a human trial of a new treatment for Type 1 diabetes:
"A new diabetes treatment developed at Northwestern University has allowed some patients to stop taking insulin for more than two years, but it also has spurred ethical objections from researchers who say the trial put Brazilian children at unnecessary risk."
